Aktis Oncology is pleased to announce our participation in the Morgan Stanley 22nd Annual Global Healthcare Conference. Matthew Roden, CEO, will be presenting on September 4th from 10:00 to 10:35 a.m. at the New York Marriott Marquis. We look forward to sharing our vision for the future of oncology and connecting with industry leaders and investors. https://lnkd.in/gxU8ZsCq
Aktis Oncology
Biotechnology Research
Realizing the curative power of alpha radiopharmaceuticals for mainstream cancer care.
About us
Aktis Oncology is a biotechnology company pioneering the discovery and development of a new class of targeted radiopharmaceuticals to treat a broad range of solid tumor cancers.
- Website
-
http://www.aktisoncology.com
External link for Aktis Oncology
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Type
- Privately Held
Employees at Aktis Oncology
Updates
-
Today, we celebrate Women's Equality Day and honor the incredible contributions women have made to cancer research and treatment. From Marie Curie's groundbreaking work on radioactivity to Dr. Jane Cooke Wright's pioneering chemotherapy research, women have been at the forefront of oncology breakthroughs for generations. At Aktis Oncology, we're proud to have talented women driving our mission forward. We remain committed to fostering an inclusive environment where all voices are heard and valued. #WomensEqualityDay #WomeninSTEM #CancerResearch #JoinUs
-
-
At Aktis Oncology, we believe in supporting our community. On Child Protection Day, our team volunteered with GIVING FACTORY DIRECT by Cradles to Crayons to address clothing insecurity affecting 22 million American children. Aktis Oncology proudly matched each donation. #ChildProtectionDay #GivingBack #cradlestocrayons
-
-
Aktis Oncology is excited to welcome three exceptional talents to our team! 👋 Paul Blanchard joins us as Scientist in the Lead Discovery Team. Paul's passion for discovering proteins for radiopharmaceutical cancer therapeutics aligns perfectly with our mission. When not in the lab, you might find him running, reading, or engaged in a competitive board game. 👋 Ryan Feaver steps in as our new Director of Molecular Pharmacology. With a background in biomedical engineering, Ryan will lead critical assay development for lead optimization. A North Carolina native and avid college basketball fan, Ryan brings a team-sport mentality to drug discovery. He's excited to return to his home state with his family. 👋 Ichiro Matsumura joins as Associate Director, bringing nearly three decades of protein engineering experience. From his postdoc days in Austin to his professorship in Atlanta, Ichiro has consistently pushed the boundaries of biochemistry. An avid cyclist (despite a college accident!), he's as resilient in life as he is innovative in the lab. The wealth of experience, passion, and unique perspectives these individuals bring to Aktis Oncology adds to our growing bench strength. Please join us in giving them a warm welcome! To learn more about our open positions, visit: https://lnkd.in/erWzsAff #NewHires #BioPharma #CancerResearch #AktisOncology #WereHiring
-
-
Aktis is pleased to announce the appointment of Akos Czibere MD, PhD, as Chief Medical Officer. Dr. Czibere brings significant clinical and scientific expertise and leadership capabilities to the role. His broad experience in oncology drug development and regulatory affairs further strengthens our capabilities to deliver our first-in-class Nectin-4-targeted miniprotein radioconjugate. Learn more: https://lnkd.in/eqN5Ztk4 #biotechnews #oncologyresearch #cancercare #radiopharmaceuticals
-
-
At Aktis Oncology, we are proud to be a part of this land of possibilities, where dreams are pursued, and innovation thrives. We remain committed to upholding the principles that our nation was founded upon, while making a positive impact on the communities we serve. #IndependenceDay #FourthOfJuly
-
-
Celebrating PRIDE together! Our teams in Boston and RTP recently gathered for a special PRIDE luncheon. We proudly supported LGBTQ+ owned businesses, Basil Tree and Indulge Catering, who provided delicious food for the event. Thank you to all our employees who joined in this celebration. Together, we support an inclusive workplace for all. #PrideMonth #Inclusion #LGBTQAllies
-
-
Today we are proud to announce the promotions of four exceptional people within our organization. Join us in congratulating: · Will Blackwell on his promotion to Director, Chemistry · Tatsiana Kosciuk on her promotion to Senior Scientist, Molecular Pharmacology · Marci Copeland on her promotion to Principal Scientist, Molecular Pharmacology · Wai Lau on his promotion to Director, Lead Discovery We are proud to have such talented individuals as part of our team and look forward to their continued achievements in their new roles. Please join us in celebrating their well-deserved success! #AktisOncology #GreatPlaceToWorkFor #GreatCompanyCulture #Collaboration #Innovation #Growth #Hiring
-
-
Our dynamic team is at the forefront of radiopharmaceutical discovery and development. If you're excited about pushing boundaries and making a lasting impact, we invite you to explore our open roles: https://lnkd.in/erWzsAff #Hiring #AktisOncology #GreatPlaceToWorkFor #GreatCompanyCulture #Collaboration #Innovation #Growth
-
-
Today, we observe Juneteenth, a pivotal moment in American history that commemorates the end of slavery in the United States. This observance holds profound significance as a symbol of inclusion for all. We encourage everyone to take this time to learn more about the rich history and enduring impact of Juneteenth by visiting the Smithsonian's National Museum of African American History and Culture's website: https://lnkd.in/gqvPZFF #Juneteenth #Reflection #Unity #Equality
-